ConductScience.org, home

Gene · 113451

AZIN2: antizyme inhibitor 2

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. AZIN2: antizyme inhibitor 2. Genes, record 113451. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/113451

On this page

Gene

Symbol
AZIN2
HGNC
Name
antizyme inhibitor 2
HGNC
NCBI Gene ID
113451
NCBI Gene
HGNC ID
HGNC:29957
HGNC
Ensembl
ENSG00000142920
NCBI Gene
Aliases
ADC, AZIB1, KIAA1945, ODC-p, ODC1L, ODCp
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q96A70Antizyme inhibitor 24600Ensembl, GeneID, HGNC

Source UniProt

Patents33

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4641201 A22025-10-293151Q96A70Espacenet
EP 4641202 A22025-10-294722Q96A70Espacenet
JP 2025517969 A2025-06-123151Q96A70Espacenet
JP 2025062604 A2025-04-145563Q96A70Espacenet
JP 2025062604 A2025-04-145566Q96A70Espacenet
KR 1020250017231 A2025-02-044722Q96A70Espacenet
US 11564998 B22023-01-315139Q96A70Espacenet
US 11564998 B22023-01-316358Q96A70Espacenet
US 11446398 B22022-09-205563Q96A70Espacenet
US 11446398 B22022-09-205566Q96A70Espacenet

1 to 10 of 33

See all 33 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants479

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleAZIN2 papersNewest fiscal year
P30CA010815Consolidated Basic Cancer Research Program42025
P30DK058404Molecular and Cellular Basis for Digestive Diseases42025
P01CA116087H. pylori-induced Inflammation and Gastric Cancer32025
P30CA006973Regional Oncology Research Center32025
P30CA016672Cancer Center Support Grant32025
P30CA008748Cancer Center Support Grant22025
P30CA016058Cancer Center Support Grant22025
P30CA076292Moffitt Cancer Center Support Grant22025
R35GM136409Integrative approaches for predicting protein interactions and applications22025
T32DK007673Training in Gastroenterology22025

1 to 10 of 479Source NIH's project files

See all 479 nih grants

Papers1,387

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
CRISPR-Cas9 mediated adiA knockout in Hafnia paralvei: Implications for agmatine production and acid stress survival in a fermented dairy matrix.Food Microbiol202742668207PubTator, text miningPubMed
Tumor-associated calcium signal transducer 2 expression as a promising therapeutic target in esophageal squamous cell carcinoma: a combined the Cancer Genome Atlas and an institutional cohort.Esophagus202642763384PubTator, text miningPubMed
Letter to the Editor: ADC as a non-invasive surrogate for PD-L1 in cervical cancer-addressing potential confounding and the leap to immunotherapy selection.Eur Radiol202642758291PubTator, text miningPubMed
Reply to the Letter to the Editor: ADC as a non-invasive surrogate for PD-L1 in cervical cancer-addressing potential confounding and the leap to immunotherapy selection.Eur Radiol202642758286PubTator, text miningPubMed
From ICI resistance to therapeutic vulnerability: A resistance-state framework for appraising antibody-drug conjugate evidence in solid tumors.Crit Rev Oncol Hematol202642754126PubTator, text miningPubMed
A framework for evaluating unexpected reactions in antibody-drug conjugates during clinical development: a case study of a promiscuous payload.MAbs202642745381PubTator, text miningPubMed
CD97/ADGRE5 in Cancer: Structural Activation, Context-Dependent Signaling, and Therapeutic Targeting.Cells202642738898PubTator, text miningPubMed
Integrated Analysis of HER2 Expression and ERBB2 Alterations in Bladder Cancer.Cancer Sci202642732768PubTator, text miningPubMed
Anti-HER2 therapy-associated echocardiography-related cardiac dysfunction and severe outcomes: Comparison of disproportionality and report-level cluster analyses.Br J Clin Pharmacol202642705876PubTator, text miningPubMed
Spatially Driven DNA-Based Probe Proximity Assay for Total Antibody Quantification in Antibody-Drug Conjugates.ACS Sens202642687273PubTator, text miningPubMed

1 to 10 of 1,387

See all 1,387 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/113451

GET https://conductscience.org/api/genes/v1/113451/patents?page=2